Rocatinlimab shows promising long-term results for Moderate to Severe Atopic Dermatitis: Lancet

Press/Media

Period	11 Dec 2022

Media coverage

Title	Rocatinlimab shows promising long-term results for Moderate to Severe Atopic Dermatitis: Lancet
Media name/outlet	Medical Dialogues
Country/Territory	India
Date	11/12/22
URL	ct.moreover.com/?a=49478871094&p=1gw&v=1&x=02rLeEIPteLfG85f5iKLFw
Persons	Emma Guttman